BridgeBio Pharma, Inc. and UC Davis Establish Collaboration to Transform Research into Potential Therapies for Genetically Driven Diseases
BridgeBio Pharma, Inc. announced a collaboration with the University of California, Davis (UC Davis), to advance research and the development of investigational medicines for patients with genetically driven conditions and cancers. “UC Davis is a top-tier research university and we feel honored to get the chance to collaborate closely with the talented team there as […]

